Mollie A Monnig1. 1. a Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health , Brown University , Providence , RI , USA.
Abstract
BACKGROUND: Emerging research points to innate immune mechanisms in the neuropathological and behavioral consequences of heavy alcohol use. Alcohol use is common among people living with HIV infection (PLWH), a chronic condition that carries its own set of long-term effects on brain and behavior. Notably, neurobiological and cognitive profiles associated with heavy alcohol use and HIV infection share several prominent features. This observation raises questions about interacting biological mechanisms as well as compounded impairment when HIV infection and heavy drinking co-occur. OBJECTIVE AND METHOD: This narrative overview discusses peer-reviewed research on specific immune mechanisms of alcohol that exhibit apparent potential to compound the neurobiological and psychiatric sequelae of HIV infection. These include microbial translocation, systemic immune activation, blood-brain barrier compromise, microglial activation, and neuroinflammation. RESULTS: Clinical and preclinical evidence supports overlapping mechanistic actions of HIV and alcohol use on peripheral and neural immune systems. In preclinical studies, innate immune signaling mediates many of the detrimental neurocognitive and behavioral effects of alcohol use. Neuropsychopharmacological research suggests potential for a feed-forward cycle in which heavy drinking induces innate immune signaling, which in turn stimulates subsequent alcohol use behavior. CONCLUSION: Alcohol-induced immune activation and neuroinflammation are a serious health concern for PLWH. Future research to investigate specific immune effects of alcohol in the context of HIV infection has potential to identify novel targets for therapeutic intervention.
BACKGROUND: Emerging research points to innate immune mechanisms in the neuropathological and behavioral consequences of heavy alcohol use. Alcohol use is common among people living with HIV infection (PLWH), a chronic condition that carries its own set of long-term effects on brain and behavior. Notably, neurobiological and cognitive profiles associated with heavy alcohol use and HIV infection share several prominent features. This observation raises questions about interacting biological mechanisms as well as compounded impairment when HIV infection and heavy drinking co-occur. OBJECTIVE AND METHOD: This narrative overview discusses peer-reviewed research on specific immune mechanisms of alcohol that exhibit apparent potential to compound the neurobiological and psychiatric sequelae of HIV infection. These include microbial translocation, systemic immune activation, blood-brain barrier compromise, microglial activation, and neuroinflammation. RESULTS: Clinical and preclinical evidence supports overlapping mechanistic actions of HIV and alcohol use on peripheral and neural immune systems. In preclinical studies, innate immune signaling mediates many of the detrimental neurocognitive and behavioral effects of alcohol use. Neuropsychopharmacological research suggests potential for a feed-forward cycle in which heavy drinking induces innate immune signaling, which in turn stimulates subsequent alcohol use behavior. CONCLUSION:Alcohol-induced immune activation and neuroinflammation are a serious health concern for PLWH. Future research to investigate specific immune effects of alcohol in the context of HIV infection has potential to identify novel targets for therapeutic intervention.
Entities:
Keywords:
Alcohol use disorder; HIV infection; behavioral neuroscience; inflammation; innate immune system; microbial translocation; neuroimaging
Authors: Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek Journal: J Infect Dis Date: 2011-01-20 Impact factor: 5.226
Authors: Jacob D Estes; Levelle D Harris; Nichole R Klatt; Brian Tabb; Stefania Pittaluga; Mirko Paiardini; G Robin Barclay; Jeremy Smedley; Rhonda Pung; Kenneth M Oliveira; Vanessa M Hirsch; Guido Silvestri; Daniel C Douek; Christopher J Miller; Ashley T Haase; Jeffrey Lifson; Jason M Brenchley Journal: PLoS Pathog Date: 2010-08-19 Impact factor: 6.823
Authors: Ece Mutlu; Ali Keshavarzian; Phillip Engen; Christopher B Forsyth; Masoumeh Sikaroodi; Patrick Gillevet Journal: Alcohol Clin Exp Res Date: 2009-07-23 Impact factor: 3.455
Authors: Sophie Leclercq; Sébastien Matamoros; Patrice D Cani; Audrey M Neyrinck; François Jamar; Peter Stärkel; Karen Windey; Valentina Tremaroli; Fredrik Bäckhed; Kristin Verbeke; Philippe de Timary; Nathalie M Delzenne Journal: Proc Natl Acad Sci U S A Date: 2014-10-06 Impact factor: 11.205
Authors: Mollie A Monnig; Joseph M Gullett; Eric C Porges; Adam J Woods; Peter M Monti; Karen Tashima; Neda Jahanshad; Paul Thompson; Talia Nir; Ronald A Cohen Journal: J Neurovirol Date: 2021-11-08 Impact factor: 3.739
Authors: Mollie A Monnig; Ronald Cohen; Bharat Ramratnam; Mikayla McAdams; Karen Tashima; Peter M Monti Journal: Alcohol Clin Exp Res Date: 2019-04-29 Impact factor: 3.455
Authors: Stephen L Schensul; Toan Ha; Jean J Schensul; James Grady; Joseph A Burleson; Sushma Gaikwad; Kavita Joshi; Rupal Malye; Avina Sarna Journal: AIDS Behav Date: 2021-05-20
Authors: Ricardo Wesley Alberca; Paula Ordonhez Rigato; Yasmim Álefe Leuzzi Ramos; Franciane Mouradian Emidio Teixeira; Anna Cláudia Calvielli Branco; Iara Grigoletto Fernandes; Anna Julia Pietrobon; Alberto Jose da Silva Duarte; Valeria Aoki; Raquel Leão Orfali; Maria Notomi Sato Journal: Front Nutr Date: 2021-06-02
Authors: Emily W Paolillo; Rowan Saloner; Maulika Kohli; C Wei-Ming Watson; Raeanne C Moore; Robert K Heaton; David J Moore Journal: J Int Neuropsychol Soc Date: 2021-07-26 Impact factor: 3.114